InsidersTradesSigma
Follow the OrbusNeich Medical Group Holdings Ltd. share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €3.3bn. The latest transaction was disclosed on 18 June 2026 (Purchase). Among the most active insiders: Chen Wing Shing. Every trade is openly available.
Analysts rate OrbusNeich Medical Group Holdings Ltd. Strong Buy (bullish), based on 2 analysts. Average price target: HK$5.61.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
OrbusNeich Medical Group Holdings Ltd. is a company specializing in the development and manufacturing of medical devices for the treatment of cardiovascular diseases. It focuses on innovation and improving clinical outcomes for patients.